Request Deal Involvement

Cheplapharm completed the acquisition of a portfolio of select prescription products from Takeda Pharmaceutical for $562m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

JP Morgan

financial advisors

JP Morgan

White & Case

legal advisors

White & Case

or

Principals

TAKEDA PHARMACEUTICAL COMPANY LIMITED (PRESCRIPTION PRODUCTS)

target

TAKEDA PHARMACEUTICAL COMPANY LIMITED (PRESCRIPTION PRODUCTS)

CHEPLAPHARM ARZNEIMITTEL GBMH

bidder

CHEPLAPHARM ARZNEIMITTEL GBMH

TAKEDA PHARMACEUTICAL COMPANY LIMITED

vendor

TAKEDA PHARMACEUTICAL COMPANY LIMITED

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Cheplapharm completed the acquisition of a portfolio of select prescription products from Takeda Pharmaceutical for $562m.